GYBYS(SH:600332) Nan Fang Du Shi Bao·2025-05-30 01:02Group 1 - Guangzhou Pharmaceutical Group is accelerating its internationalization strategy, participating in the ASEAN-GCC-China Economic Forum in Kuala Lumpur [1][2] - The company has signed production cooperation agreements with Malaysia's Baosteel Can and P.C.I. to establish localized production in Southeast Asia [1][3] - The chairman of Guangzhou Pharmaceutical Group, Li Xiaojun, emphasized the importance of adapting to international markets through localized branding and packaging innovations [2][3] Group 2 - The partnership with Baosteel Can, which has an annual production capacity of 800 million cans, marks the first project from a global strategic cooperation agreement signed in April [3] - The trade volume between China and Malaysia has increased from less than $200 million at the beginning of diplomatic relations to $212 billion, reflecting over a thousand-fold growth [3] - The company aims to enhance its operational capabilities in Southeast Asia through these partnerships, moving towards a comprehensive and systematic production and sales model [3]